\
&
Contact us
\
&
Contact us
Starts in 2 weeks from now
Locationonline
ProgrammesThe mission on climate adaptation wants to direct policy makers, researchers, citizens, businesses etc. towards the general objective of making the EU more climate resilient by 2030. One of the means of achieving this is by bringing people together from all corners of society to discuss the progress towards this goal.
To this purpose, the European Commission organises the Mediterranean Forum on the Mission on Adaptation to Climate Change. The event will highlight multi-level governance as a key driver of climate action in the Mediterranean area, showcasing how Charter Signatories and regional and local authorities address the related climate challenges.
This event is by invitation only if you want to be present on-site in Bologna but everybody can watch it online on this website where you can also find more information about the programme.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Digital, Industry & Space Climate, Energy, Mobility EIC EIE
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
